Reactions Weekly

, Volume 1695, Issue 1, pp 335–335 | Cite as


Nausea: case report
Case report


  1. Nazario HE, et al. Full dose, daily sofosbuvir treatment in end-stage renal disease: Tolerability & safety of largest ESRD patient cohort exposed to this drug. Journal of Hepatology 66 (Suppl. 1): S506-S507, No. 1, 2017 [abstract] -USAGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations